Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 30;12(11):1298.
doi: 10.3390/pathogens12111298.

Invasive and Non-Invasive Human Salmonellosis Cases Admitted between 2015 and 2021 in Four Suburban Hospitals in the Metropolitan Area of Milan (Italy): A Multi-Center Retrospective Study

Gabriele Pagani  1 , Marco Parenti  2 , Marco Franzetti  1 , Laura Pezzati  1   2 , Francesco Bassani  1   2 , Bianca Osnaghi  3 , Laura Vismara  3 , Claudia Pavia  3 , Paola Mirri  3 , Stefano Rusconi  1   2
Affiliations

Invasive and Non-Invasive Human Salmonellosis Cases Admitted between 2015 and 2021 in Four Suburban Hospitals in the Metropolitan Area of Milan (Italy): A Multi-Center Retrospective Study

Gabriele Pagani et al. Pathogens. .

Abstract

Non-Typhoidal Salmonellas (NTSs) are diffused worldwide. In Italy, more than 3500 cases are notified each year, but despite this, data about salmonellosis are scarce. Our multi-center, retrospective, descriptive study selected 252 patients with positive cultures for Salmonella spp. (feces 79.8%, blood 8.7%, feces and blood 7.5%), aiming to describe the epidemiological and clinical characteristics of this population. Bacteremic infections constituted 16.3% (41/252) of patients. Extreme ages (≤12 and ≥65 years old) accounted for 79.7%, but only elder ages were strongly associated with bacteremic infections (aOR 5.78). Invasive infections had a 7-fold higher mortality rate than non-invasive disease (9.8% vs. 1.4%, p = 0.013), with an overall rate of 2.8%. The two more represented serogroups were O:4 (52.8%) and O:9 (22.2%). The O:9 serogroup was strongly associated with a higher frequency of invasive infection (aOR 2.96, 95% CI 1.17-7.63). In particular, S. napoli, an emerging serovar in Europe, accounted for 31.7% of bacteremic infections and only 9.5% of non-bacteremic ones (p < 0.001). Antibiotic microbial resistance (AMR) observed a steep increasing trend and was detected in 60.4% of cases (122/202): amoxicillin/clavulanate, ampicillin, and gentamicin were most commonly involved (26.7%, 21.8%, 14.3%, respectively), while TMP/SMX, ciprofloxacin, and ceftriaxone were <10%. Resistance was, in general, less common in the O:9 serogroup, while amikacin resistance was significantly more common. Factors associated with an MDR Salmonella acquisition were time (OR 1.37 per year more), O:4 serogroup (OR 2.67), and being a woman (OR 2.11). The most frequent symptoms were diarrhea (90.5%) and fever (81.7%). In conclusion, our study highlights a high burden of NTS infections, leading to severe or fatal outcomes in frail patients. Furthermore, AMR shows an increasing trend with a concerning high prevalence of cephalosporine resistance compared to the rest of Europe.

Keywords: NTS; Salmonella; invasive; non-typhoidal; northern-Italy; zoonoses.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Number of proven Salmonella infections in hospitalized patients by year of observation (2015–2021).
Figure 2
Figure 2
Hospitalized patients: distribution by age and sex.
Figure 3
Figure 3
Absolute frequencies of the chosen first-line antibiotic agents.
See this image and copyright information in PMC

References

    1. Giannella R.A. Salmonella. In: Baron S., editor. Medical Microbiology. University of Texas Medical Branch at Galveston; Galveston, TX, USA: 1996. [(accessed on 15 March 2023)]. Available online: https://www.ncbi.nlm.nih.gov/books/NBK8435/
    1. GBD 2017 Typhoid and Paratyphoid Collaborators The global burden of typhoid and paratyphoid fevers: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect. Dis. 2019;19:369–381. - PMC - PubMed
    1. Authority E.F.S., European Centre for Disease Prevention and Control The European Union One Health 2021 Zoonoses Report. EFSA J. 2022;20:e07666. - PMC - PubMed
    1. Feasey N.A., Dougan G., Kingsley R.A., Heyderman R.S., Gordon M.A. Invasive non-typhoidal salmonella disease: An emerging and neglected tropical disease in Africa. Lancet. 2012;379:2489–2499. doi: 10.1016/S0140-6736(11)61752-2. - DOI - PMC - PubMed
    1. Lan N.P.H., Le Thi Phuong T., Huu H.N., Thuy L., Mather A.E., Park S.E., Marks F., Thwaites G.E., Van Vinh Chau N., Thompson C.N., et al. Invasive Non-typhoidal Salmonella Infections in Asia: Clinical Observations, Disease Outcome, and Dominant Serovars from an Infectious Disease Hospital in Vietnam. PLoS Negl. Trop. Dis. 2016;10:e0004857. - PMC - PubMed

LinkOut - more resources